SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-022654
Filing Date
2021-09-27
Accepted
2021-09-27 08:45:35
Documents
18
Period of Report
2021-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20210926_8k.htm   iXBRL 8-K 37712
2 EXHIBIT 10.1 ex_286562.htm EX-10.1 284044
3 EXHIBIT 10.2 ex_286563.htm EX-10.2 94495
4 EXHIBIT 99.1 ex_286564.htm EX-99.1 12573
9 dialogo.jpg GRAPHIC 8981
10 remlogo.jpg GRAPHIC 5139
  Complete submission text file 0001437749-21-022654.txt   666180

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dmtp-20210926.xsd EX-101.SCH 3594
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmtp-20210926_def.xml EX-101.DEF 11410
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmtp-20210926_lab.xml EX-101.LAB 15281
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmtp-20210926_pre.xml EX-101.PRE 11570
11 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20210926_8k_htm.xml XML 2559
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 211279074
SIC: 2834 Pharmaceutical Preparations